|
[1]
|
Evans, L., Rhodes, A., Alhazzani, W., et al. (2021) Surviving Sepsis Campaign: International Guidelines for Manage-ment of Sepsis and Septic Shock 2021. Intensive Care Medicine, 47, 1181-1247. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Fleischmann-Struzek, C., Mellhammar, L., Rose, N., et al. (2020) Incidence and Mortality of Hospital- and ICU-Treated Sepsis: Results from an Updated and Expanded Systematic Re-view and Meta-Analysis. Intensive Care Medicine, 46, 1552-1562. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Lerner, A.B., Case, J.D., Takahashi, Y., Lee, T.H. and Mori, W. (1958) Isolation of Melatonin, the Pineal Gland Factor That Lightens Melanocytes1. Journal of the American Chemical Society, 80, 2587-2587. [Google Scholar] [CrossRef]
|
|
[4]
|
Pandi-Perumal, S.R., Srinivasan, V., Maestroni, G.J., et al. (2006) Mel-atonin: Nature’s Most Versatile Biological Signal? The FEBS Journal, 273, 2813-2838. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Slominski, A., Tobin, D.J., Zmijewski, M.A., Wortsman, J. and Paus, R. (2008) Melatonin in the Skin: Synthesis, Metabolism and Functions. Trends in Endocrinology and Metabo-lism, 19, 17-24. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Bubenik, G.A. (2002) Gastrointestinal Melatonin: Localization, Function, and Clinical Relevance. Digestive Diseases and Sciences, 47, 2336-2348. [Google Scholar] [CrossRef]
|
|
[7]
|
Reiter, R.J., Calvo, J.R., Karbownik, M., Qi, W.B. and Tan, D.X. (2000) Melatonin and Its Relation to the Immune System and Inflammation. Annals of the New York Academy of Sciences, 917, 376-386. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Sánchez-López, A.L., Ortiz, G.G., Pacheco-Moises, F.P., et al. (2018) Efficacy of Melatonin on Serum Pro-Inflam- matory Cytokines and Oxidative Stress Markers in Relapsing Remitting Multiple Sclerosis. Archives of Medical Research, 49, 391-398. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Hasan, Z.T., Atrakji, D. and Mehuaiden, D.A.K. (2022) The Ef-fect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients. International Journal of Infectious Diseases, 114, 79-84. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Jehi, L., Ji, X., Milinovich, A., et al. (2020) Individualizing Risk Prediction for Positive Coronavirus Disease 2019 Testing: Results from 11,672 Patients. Chest, 158, 1364-1375. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Huang, S.H., Liao, C.L., Chen, S.J., et al. (2019) Melatonin Pos-sesses an Anti-Influenza Potential through Its Immune Modulatory Effect. Journal of Functional Foods, 58, 189-198. [Google Scholar] [CrossRef]
|
|
[12]
|
Carrillo-Vico, A., Lardone, P.J., Naji, L., et al. (2005) Beneficial Pleiotropic Actions of Melatonin in an Experimental Model of Septic Shock in Mice: Regulation of Pro-/Anti-Inflammatory Cytokine Network, Protection against Oxidative Damage and Anti-Apoptotic Effects. Journal of Pineal Research, 39, 400-408. [Google Scholar] [CrossRef]
|
|
[13]
|
Cuzzocrea, S., Costantino, G., Mazzon, E. and Caputi, A.P. (1999) Regulation of Prostaglandin Production in Carrageenan-Induced Pleurisy by Melatonin. Journal of Pineal Re-search, 27, 9-14. [Google Scholar] [CrossRef]
|
|
[14]
|
Zhao, L., An, R., Yang, Y., et al. (2015) Melatonin Al-leviates Brain Injury in Mice Subjected to Cecal Ligation and Puncture via Attenuating Inflammation, Apoptosis, and Oxidative Stress: The Role of SIRT1 Signaling. Journal of Pineal Research, 59, 230-239. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Cuzzocrea, S., Zingarelli, B., Costantino, G. and Caputi, A.R. (1998) Protec-tive Effect of Melatonin in a Non-Septic Shock Model Induced by Zymosan in the Rat. Journal of Pineal Research, 25, 24-33. [Google Scholar] [CrossRef]
|
|
[16]
|
Reiter, R.J., Acuña-Castroviejo, D., Tan, D.X. and Burkhardt, S. (2001) Free Radical-Mediated Molecular Damage: Mechanisms for the Protective Actions of Melatonin in the Central Nervous System. Annals of the New York Academy of Sciences, 939, 200-215. [Google Scholar] [CrossRef]
|
|
[17]
|
Mauriz, J.L., Molpeceres, V., Garcia-Mediavilla, M.V., et al. (2007) Melatonin Prevents Oxidative Stress and Changes in Antioxidant Enzyme Expression and Activity in the Liver of Aging Rats. Journal of Pineal Research, 42, 222-230. [Google Scholar] [CrossRef]
|
|
[18]
|
Sewerynek, E., Abe, M., Reiter, R.J., et al. (1995) Melato-nin Administration Prevents Lipopolysaccharide-Induced Oxidative Damage in Phenobarbital-Treated Animals. Journal of Cellular Biochemistry, 58, 436-444. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Carrillo-Vico, A., Lardone, P.J., Alvarez-Sánchez, N., Rodríguez-Rodríguez, A. and Guerrero, J.M. (2013) Melatonin: Buffering the Immune System. International Journal of Molecular Sciences, 14, Article 8638. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Akbulut, K.G., Gönül, B. and Akbulut, H. (2001) The Effects of Mela-tonin on Humoral Immune Responses of Young and Aged Rats. Immunological Investigations, 30, 17-20. [Google Scholar] [CrossRef]
|
|
[21]
|
Winczyk, K., Pawlikowski, M. and Karasek, M. (2001) Melatonin and RZR/ROR Receptor Ligand CGP 52608 Induce Apoptosis in the Murine Colonic Cancer. Journal of Pineal Re-search, 31, 179-182. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Liu, H., Xu, L., Wei, J.E., Wang, S.E. and Zhou, R.X. (2011) Role of CD4+ CD25+ Regulatory T Cells in Melatonin-Mediated Inhibition of Murine Gastric Cancer Cell Growth in Vivo and in Vitro. Anatomical Record, 294, 781-788. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Bagci, S., Horoz, Ö., Yildizdas, D., et al. (2012) Melatonin Status in Pediat-ric Intensive Care Patients with Sepsis. Pediatric Critical Care Medicine, 13, e120-e123. [Google Scholar] [CrossRef]
|
|
[24]
|
Lorente, L., Martín, M.M., Abreu-Gonzalez, P., et al. (2015) Serum Melatonin Levels Are Associated with Mortality in Severe Septic Patients. Journal of Critical Care, 30, 860.e1-860.e6. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Wu, J.Y., Tsou, M.Y., Chen, T.H., et al. (2008) Therapeutic Effects of Melatonin on Peritonitis-Induced Septic Shock with Multiple Organ Dysfunction Syndrome in Rats. Journal of Pineal Research, 45, 106-116. [Google Scholar] [CrossRef]
|
|
[26]
|
Rahim, I., Djerdjouri, B., Sayed, R.K., et al. (2017) Mela-tonin Administration to Wild-Type Mice and Nontreated NLRP3 Mutant Mice Share Similar Inhibition of the Inflamma-tory Response during Sepsis. Journal of Pineal Research, 63, e12410. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Gitto, E., Karbownik, M., Reiter, R.J., et al. (2001) Effects of Melatonin Treatment in Septic Newborns. Pediatric Research, 50, 756-760. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Galley, H.F., Allen, L., Colin, P.J., Galt, S.P. and Webster, N.R. (2022) Dose Assessment of Melatonin in Sepsis (DAMSEL2) Study: Pharmacokinetics of Two Doses of Oral Melatonin in Patients with Sepsis. Journal of Pineal Research, 73, e12830. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Mansilla-Roselló, A., Hernandez-Magdalena, J., Dominguez-Bastante, M., et al. (2023) A Phase II, Single-Center, Double-Blind, Randomized Placebo-Controlled Trial to Explore the Efficacy and Safety of Intravenous Melatonin in Surgical Patients with Severe Sepsis Admitted to the Intensive Care Unit. Journal of Pineal Research, 74, e12845. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Vine, T., Brown, G.M. and Frey, B.N. (2022) Melatonin Use during Preg-nancy and Lactation: A Scoping Review of Human Studies. Brazilian Journal of Psychiatry, 44, 342-348. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Seabra, M.L., Bignotto, M., Pinto Jr, L.R. and Tufik, S. (2000) Randomized, Double-Blind Clinical Trial, Controlled with Placebo, of the Toxicology of Chronic Melatonin Treatment. Journal of Pineal Research, 29, 193-200. [Google Scholar] [CrossRef] [PubMed]
|